| |
| |
|
| Insider
Information: |
Brown Michael S |
| Relationship: |
Director |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
1,382 |
|
|
Indirect Shares
|
11,162 |
|
|
| Direct
Value |
$1,324,840 |
|
|
|
Indirect Value
|
$10,700,340 |
|
|
| Total
Shares |
12,544 |
|
|
| Total
Value |
$12,025,180 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
3
|
|
Stock
price went up :
|
0
|
2
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
2.0
|
| Percentage
Gain/Loss : |
0.0%
|
 23.6%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Regeneron Pharmaceuticals Inc |
REGN |
Director |
2024-01-02 |
1,382 |
2024-01-02 |
11,162 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2024-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
135 |
1,382 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2023-12-27 |
4 |
AS |
$898.00 |
$1,840,002 |
D/D |
(2,049) |
1,247 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2023-12-27 |
4 |
OE |
$482.68 |
$989,011 |
D/D |
2,049 |
3,296 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2023-04-21 |
4 |
AS |
$798.42 |
$2,451,149 |
D/D |
(3,070) |
1,247 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2023-04-21 |
4 |
OE |
$520.01 |
$1,596,431 |
D/D |
3,070 |
4,317 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2023-02-06 |
4 |
OE |
$520.01 |
$1,596,951 |
D/D |
3,071 |
4,318 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2023-02-06 |
4 |
AS |
$798.00 |
$2,450,658 |
D/D |
(3,071) |
1,247 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2023-02-06 |
4 |
AS |
$797.00 |
$398,500 |
I/I |
(500) |
6,162 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2023-01-27 |
4 |
OE |
$520.01 |
$520 |
D/D |
1 |
1,248 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2023-01-27 |
4 |
AS |
$747.00 |
$747 |
D/D |
(1) |
1,247 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2023-01-06 |
4 |
OE |
$520.01 |
$1,596,431 |
D/D |
3,070 |
4,317 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2023-01-06 |
4 |
AS |
$747.14 |
$2,293,720 |
D/D |
(3,070) |
1,247 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2023-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
165 |
1,247 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2022-11-08 |
4 |
AS |
$748.49 |
$374,245 |
I/I |
(500) |
6,662 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2022-11-08 |
4 |
AS |
$748.48 |
$3,016,946 |
D/D |
(3,995) |
1,082 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2022-11-08 |
4 |
OE |
$374.12 |
$1,664,397 |
D/D |
3,995 |
3,313 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2022-03-30 |
4 |
OE |
$374.12 |
$152,641 |
D/D |
408 |
1,490 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2022-03-30 |
4 |
AS |
$699.00 |
$285,192 |
D/D |
(408) |
1,082 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2022-03-29 |
4 |
AS |
$699.00 |
$1,063,878 |
D/D |
(1,522) |
1,082 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2022-03-29 |
4 |
OE |
$374.12 |
$569,411 |
D/D |
1,522 |
2,604 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2022-02-23 |
4 |
S |
$608.68 |
$304,340 |
I/I |
(500) |
7,162 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2022-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
191 |
1,082 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2021-09-13 |
4 |
AS |
$636.74 |
$6,289,792 |
D/D |
(9,704) |
891 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2021-09-13 |
4 |
OE |
$380.95 |
$3,930,684 |
D/D |
9,704 |
10,595 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2021-08-09 |
4 |
S |
$612.38 |
$1,033,085 |
I/I |
(1,687) |
7,662 |
0 |
% |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
